Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aphaia, Astrazeneca, Biomea Fusion, Bristol Myers Squibb, Galera, Genentech, GSK, Homology Medicines, Hutchmed, Intrommune, Kintor, Melt, Mustang, Muvon, Neurocrine, Nykode, Omega, Puma, Q32, Roche.